Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 1/20 | 0.37 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.36 |
| ▸ | CASP6 | P55212 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2200685 | 0.84 | MC4R (0.48) | MC4RALDH1A1RAB9A | |
| SCHEMBL1055261 | 0.81 | KAT2B (0.37) | MC4RKAT2BALDH1A1 | |
| SCHEMBL2201250 | 0.80 | MAPT (0.36) | KAT2BCASP6ALDH1A1MAPTRAB9A | |
| SCHEMBL2201162 | 0.80 | ALDH1A1 (0.36) | MC4RALDH1A1MAPT | |
| SCHEMBL1057117 | 0.80 | MAOB (0.43) | MC4RKAT2BALDH1A1 | |
| SCHEMBL2200129 | 0.79 | CYP1A2 (0.46) | MC4RKAT2BALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL27715897 | 0.72 | CYP3A4 (0.49) | CASP6ALDH1A1MAPTSMN1; SMN2POLB | |
| SCHEMBL7537975 | 0.72 | MC4R (0.51) | MC4RALDH1A1RAB9A | |
| SCHEMBL16924651 | 0.69 | GPR35 (0.38) | KAT2BALDH1A1 | |
| SCHEMBL11027254 | 0.69 | CASP6 (0.41) | CASP6ALDH1A1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1909142-B1 | PHOTOSENSITIVE RESIN COMPOSITION AND ADHESION ENHANCER | TORAY INDUSTRIES (JP) | 2015-06-24 | — | — | EP | disclosed |
| US-7977028-B2 | Photosensitive resin composition and adhesion promoter | TORAY INDUSTRIES, INC. (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20090123867-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND ADHESION PROMOTER | TORAY INDUSTRIES, INC. (JP) | 2009-05-14 | — | — | US | disclosed |
| EP-1909142-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND ADHESION ENHANCER | TORAY INDUSTRIES, INC. (JP) | 2008-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090123867-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND ADHESION PROMOTER | PCNA, TERB1, SMC2 | MC4R 4113/4885KAT2B 400/4885CASP6 4346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.